Sector: Pharmaceuticals & Biotechnology

Small Cap

Mono Pharmacare Share Price

Q: What is the Market Capitalization of Mono Pharmacare Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Mono Pharmacare Ltd. is approximately ₹ 21.6 Cr.

Q: What are the PE and PB ratios for Mono Pharmacare Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Mono Pharmacare Ltd. is 7, and the Price-to-Book (PB) ratio is 0.7.

Q: What is the 52-Week High and Low for Mono Pharmacare Ltd.?

Over the past 52 weeks, the highest price reached by Mono Pharmacare Ltd. shares was ₹ 28.25, and the lowest price was ₹ 9.45.

Q: Who are the major shareholders of Mono Pharmacare Ltd.?

Significant shareholdings in Mono Pharmacare Ltd. typically include entities such as: Promoter Public Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Mono Pharmacare Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Mono Pharmacare Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

Mono Pharmacare Ltd.

₹12.25

0.20(1.66%)

Trade Now

27th May 2026 | 9:52 AM

NSE : MONOPHARMA

Open Free Demat Account

Mono Pharmacare Performance

Price Movement

₹12.25

₹11.45

₹12.25

↘ Today's Low↗ Today's High

1 Year Performance

₹12.25

₹9.45

₹28.25

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹12.25

Low₹11.45

Open at₹11.45

Prev Close₹12.05

Volumes6.00 K

Avg Price₹11.71

Lower Circuit₹11.45

Upper Circuit₹12.65

Historical Performance

3M High₹13.95

3M Low₹10.85

1 Yr High₹28.25

1 Yr Low₹9.45

3 Yr High₹75.00

3 Yr Low₹9.45

5 Yr High₹75.00

5 Yr Low₹9.45

Mono Pharmacare Fundamentals

Market Cap

Low in industry

21.60 Cr.

PE Ratio (TTM)

Low in industry

Dividend Yield

Net Profit TTM

Net profit TTM

Net Profit Growth

Net profit TTM

PEG Ratio

ROE

13.8% incr over last year

9.95

Operating Revenue TTM

Operating Revenue Growth

Operating Revenue TTM

Book Value

Low in industry

0.70

MFI

MFI is mid-range

35.29

RSI

RSI is mid-range

47.78

EPS (TTM)

1.75

Debt to Equity

1.72

Face Value

Operating Profit Margin Qtr.

4.51

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

0.70

Mono Pharmacare Financials

Data not available for chart

Indicator
No Record Found

Mono Pharmacare Technicals

Mono Pharmacare Ltd. EMA & SMA

₹12.25

0.20 (1.66%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹12

Day EMA10 ₹12.2

Day EMA12 ₹12.2

Day EMA20 ₹12.3

Day EMA26 ₹12.3

Day EMA50 ₹12.8

Day EMA100 ₹15

Day EMA200 ₹19.7

Mono Pharmacare Support and Resistance

Resistance

First Resistance₹12.05

Second Resistance₹12.05

Third Resistance₹12.05

Support

First Support₹12.05

Second Support₹12.05

Third Support₹12.05

Technical Indicators

Day RSI47.78

Day MFI35.29

Day ADX14.76

Day Commodity Channel Index-46.90

William-67.86

Day MACD-0.07

Day MACD Signal Line0.07

Day ATR0.60

Day ROC125-47.15

Day ROC218.07

Mono Pharmacare Shareholding Pattern

Held By	Sep 2024	Mar 2025	Sep 2025
Promoter	56.7	56.7	56.7
FII	0	0	0
DII	0	0	0
Public	43.3	43.3	43.3

Mono Pharmacare Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	8 K	8 K	100.00%
Week	7 K	8 K	87.50%
1 Month	0	0	undefined%
6 Month	11.04 K	12.56 K	87.89%

Mono Pharmacare SWOT Analysis

Strengths12

Weakness7

Opportunity0

Threats0

Positive Breakout Third Resistance ( LTP > R3)

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Week

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Top Gainers

Mono Pharmacare Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Mono Pharmacare Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Medistep Healthcare Ltd.
Price (₹)	₹486.75	₹6.46	₹121.85	₹132.26	₹14.29	₹19
% Change	0.64%	0.00%	-0.12%	-0.74%	1.71%	-2.31%
Revenue TTM (₹ Cr)	-	₹83.60	-	₹287.68	-	-
Net Profit TTM (₹ Cr)	-	₹-34.95	-	₹14.88	-	-
PE TTM	-	-1.50	16.10	34.40	-	6.50
1 Year Return	23.66	545	-4.8	4.6	56.59	-55.81
ROCE	3.56	-5.63	-	-	-	-

Similar Stocks

INFLUX

Influx Healthtech Ltd.

₹ 232.40

-0.49%

MEDIORG

Medicamen Organics Ltd.

₹ 24.00

+0.00%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 563.80

+1.08%

INNOVACAP

Innova Captab Ltd.

₹ 844.00

+0.06%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 80.00

+1.60%

SIGACHI

Sigachi Industries Ltd.

₹ 20.57

+1.33%

WINDLAS

Windlas Biotech Ltd.

₹ 821.00

-0.22%

VINEETLAB

Vineet Laboratories Ltd.

₹ 35.00

+0.43%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 544.00

-2.60%

ZIMLAB

Zim Laboratories Ltd.

₹ 102.60

-0.77%

MEDICO

Medico Remedies Ltd.

₹ 49.00

+1.51%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 197.52

-1.50%

LASA

Lasa Supergenerics Ltd.

₹ 8.63

+4.99%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 372.20

-1.22%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 311.50

+2.05%

ORTINGLOBE

Ortin Global Ltd.

₹ 16.31

+4.95%

BROOKS

Brooks Laboratories Ltd.

₹ 62.19

+5.00%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2239.00

+1.14%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 129.90

-0.20%

ALPA

Alpa Laboratories Ltd.

₹ 71.15

+0.66%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 378.90

+0.70%

NECLIFE

Nectar Lifesciences Ltd.

₹ 12.41

+1.14%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 28.70

-0.66%

INDOCO

Indoco Remedies Ltd.

₹ 203.00

+5.11%

FAQ's on MONOPHARMA

What is the Market Capitalization of Mono Pharmacare Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Mono Pharmacare Ltd. is approximately ₹ 21.6 Cr.

What are the PE and PB ratios for Mono Pharmacare Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Mono Pharmacare Ltd. is 7, and the Price-to-Book (PB) ratio is 0.7.

What is the 52-Week High and Low for Mono Pharmacare Ltd.?

Over the past 52 weeks, the highest price reached by Mono Pharmacare Ltd. shares was ₹ 28.25, and the lowest price was ₹ 9.45.

Who are the major shareholders of Mono Pharmacare Ltd.?

Significant shareholdings in Mono Pharmacare Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Mono Pharmacare Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Mono Pharmacare Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy